Keywords: watson, bph, drug, silodosin, enters, ph, iii

Watson's BPH drug Silodosin enters Ph III

Article | 20 June 2005

USA-based specialty drugmaker Watson Pharmaceuticals has commenced Phase III clinical studies on silodosin, its investigational drug developed to treat the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Watson Pharmaceuticals

Go to company listing